Rexahn Pharmaceuticals, Inc. (RNN)

0.57
+0.00 (+0.00%)
Exchange
ASE
Day Range
0.52 - 0.54
52 Week Range
0.52 - 0.96
Open
0.53
Avg. Vol
597,054
Market Cap
95.17M
Short ratio
7.80
PE ratio
PEG Ratio
0.00
Earnings Share
-0.05
Bid
0.52
Book Value
0.13
EPS Current Year Estimate
-0.07
EPS Estimate Next Year
-0.04
Change from Year Low
0.01
Change from Year High
-0.43
Price Target 1 Year
2.58

Complete Profile

Name Rexahn Pharmaceuticals, Inc.
Sector Healthcare
Industry Biotechnology
Address

Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road
Suite 455
Rockville, MD 20850
United States - Map
Phone: 240-268-5300
Fax: 240-268-5310
Website: http://www.rexahn.com

Employees 22
Executives Dr. Peter D. Suzdak Ph.D.
Chief Exec. Officer and Director


Mr. Rakesh Soni
Pres and Chief Operating Officer


Dr. Chang H. Ahn Ph.D.
Founder Chairman Emeritus and Chief Scientist


Dr. Tae Heum Jeong D. Mgt.
Chief Financial Officer Sr. VP and Sec.


Dr. Ely Benaim M.D.
Chief Medical Officer


Holders
  • Vanguard Total Stock Market Index Fund
  • Vanguard Extended Market Index Fund
  • Spartan Extended Market Index Fund
  • Spartan Total Market Index Fund
  • Bridgeway Funds Inc-Ultra Small Company Market Fund
  • AQR Funds-AQR Small Cap Momentum Style Fd
  • Vanguard Balanced Index Fund
  • Quantitative Master Series Tr-Extended Market Index Series
  • Claymore ETF Tr-Wilshire Micro Cap ETF
  • AQR Funds-AQR TM Small Cap Momentum Style Fd